Jiuzhou Pharma to buy Sandoz finished drugs plant in Zhongshan for $15.1 M
The Chinese firm also plans to refurbish and expand the facility, altogether redirecting $18.5 million of capital to the Sandoz project.<br />
Jiuzhou Pharmaceutical | 29/09/2022 | By Sudeep Soparkar | 810
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy